Does Novavax, Inc. (NVAX)'s current closing price competes the market?

Investors and Traders continue to monitor technical levels of shares of Novavax, Inc.

According to Zacks, "NOVAVAX INC is a specialty biopharmaceutical company engaged in the research, development and commercialization of proprietary products focused on women's health and infectious diseases".

Novavax, Inc. (NVAX) now has P/E (Price to Earnings) ratio of 0 while the company's industry has 246.8 P/E and the sector P/E is 19.12. The stock now has Monthly Volatility of 6.65% and Weekly Volatility of 4.58%.

An earnings forecast is an analyst's outlook for a company's future quarterly or annual earnings.

The company's Average Earnings Estimate for the Current Fiscal quarter is $-0.16, according to consensus of 7 analysts. In contrast to the year ago quarter EPS was at -0.25.

Novavax, Inc. (NVAX) reported sales (ttm) of 16.8 Million, whereas, 6 number of analysts estimated the mean sale of 5.98 million. For the current year the company's revenue estimates are $25.11 Million compared to low analyst estimates of $22 Million and high estimates of $29.2 Million according to the prediction of 6 analysts. Chardan Capital restated a hold rating and issued a $1.50 price target on shares of Novavax in a research report on Tuesday, February 28th. The company now has a consensus rating of Hold and a consensus target price of $5.56. After a recent check, Novavax, Inc. The stock's 50 day moving average is $0.95 and its 200 day moving average is $1.21. Simple moving average analysis helps investors to quickly identify if a security is in an uptrend or downtrend.

The SMA20 for the stock is at 12.31 percent, SMA50 stands at 23.58 percent, while SMA200 is -21.4 Percent. Earnings per share serves as an indicator of a company's profitability.

Management effectiveness shows return on equity and return on assets for the trailing twelve months at -315.44% and -30.28% respectively. The firm has a Return on Assets (ROA) value of -56.70%.

Now the shares of Novavax, Inc.

Return on Investment measures the amount of return on an investment relative to the investment's cost. (NVAX) is 0 percent. It has a return on equity (ROE) of -787.40%. Norges Bank acquired a new stake in shares of Novavax during the fourth quarter worth about $3,300,000. The stock exchanged hands 11.05 Million shares versus average trading capacity of 6.23 Million shares. The company's average Piotroski F-Score: 3 during the last 7 years. Novavax, Inc. has a 52-week low of 0.73 and a 52-week high of 8.49. They may also be used to assist the trader figure out proper support and resistance levels for the stock. It helps investors in determining whether buying, selling or holding on to a stock would be beneficial for them. The average revenue per share growth rate of Novavax, Inc. during the past 12 months was -45.6 percent.

Like this



27 June 2017
$-1.71 EPS Expected for Alder Biopharmaceuticals Inc (ALDR)
Exxonmobil Investment Management Tx invested 1.4% of its portfolio in Facebook Inc (NASDAQ:FB). 125 are held by Estabrook Capital. The stock has performed -0.53% over the last seven days, 9.68% over the last thirty, and -12.62% over the last three months.

27 June 2017
Serco Group plc (SRP) Receives GBX 141.91 Consensus Target Price from Analysts
After $0.46 actual earnings per share reported by BP plc for the previous quarter, Wall Street now forecasts 117.39% EPS growth. AdEPT Telecom plc ( LON:ADT ) traded up 0.76% during midday trading on Wednesday, hitting GBX 332.50.

27 June 2017
Intercontinental Exchange Inc. (ICE) Receives Average Rating of "Buy" from Brokerages
Guardian Life Insurance Co. of America increased its stake in shares of Intercontinental Exchange by 0.7% in the first quarter. In related news, Director Jean Marc Forneri sold 4,000 shares of the firm's stock in a transaction dated Thursday, June 8th.

27 June 2017
Boeing Beats Airbus; Shares Set To Fall
Boeing now expects 29,530 deliveries in the medium-haul single-aisle category, which is popular with low-priced airlines. CBD Aviation, which on Monday bought planes from Boeing , signed for 45 Airbus narrowbodies on Tuesday.

27 June 2017
Aramazd Andressian Sr., Father of Missing Boy, Arrested
While the police are searching for the missing child, they are also investigating why his father was passed out in the park. He told police he had taken prescription pills that belonged to someone else and did not know what had happened to his son.

27 June 2017
Sonic Mania vinyl album announced
The collector's edition comes with a 12-inch Sonic the Hedgehog figurine that's standing on top of a replica Sega Genesis console. The inner sleeve of the album also includes artwork of the characters found throughout the game.

27 June 2017
Mattis blames Congress for lack of military readiness
The defense secretary's remarks Tuesday to the Senate Armed Services Committee followed criticism from the panel's chairman, Sen. In the last ten years, Congress has passed 30 separate stopgap budget measures, he said . "It's about authorities.

27 June 2017
Sibanye Gold Ltd (ADR) (NYSE:SBGL), Coherus Biosciences Inc (NASDAQ:CHRS)
One analyst has rated the stock with a sell rating, one has assigned a hold rating and seven have given a buy rating to the stock. Coherus , which is developing various biosimilars, has also submitted an application to market its Neulasta copy in Europe.

27 June 2017
Ecommerce firms get a breather on TDS, TCS
At that time, Finance Ministry had reminded them about billion dollar valuations, and the profits made by them. When that merchant pays GST later, then this tax payment will be credited back under tax collected at source.

27 June 2017
What's Propelling InterXion Holding NV (INXN) to Reach 52-Week High?
Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company's stock. The stock of InterXion Holding NV (NYSE:INXN) earned "Overweight" rating by Barclays Capital on Monday, September 28.